Aurora Cannabis Inc (ACB)
$2.63 0.03 (1.15%)
19:57 EST ACB Stock Quote Delayed 15 Minutes
Previous Close $2.63
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 24.75M
Day's Range 2.59 - 2.74
52-Week Range 2.14 - 10.32
Dividend & Yield N/A (N/A)
ACB Stock Predictions, Articles, and Aurora Cannabis Inc News
- From InvestorPlace
- From the Web
A trade deal did not result in the type of action stock market bulls were hoping for. Here's what happened in the stock market today.
Presently depressed Canadian consumer cannabis demand trends could reverse in 2020. If they do, Aurora Cannabis could rebound in a big way.
Downside risks persist for Aurora stock and the cannabis industry, but there may be more than just hope around tomorrow’s corner
Aurora stock continues to fall, and its risk seems to be accelerating. But the imminent risk is more issuance of ACB stock, not bankruptcy.
Expect more dilution, debt, deficits, and a deep drop in Aurora stock. Aurora Cannabis free cash flow losses will require more debt and dilution.
Options trading was buzzing in Freeport-McMoRan, Canopy Growth and Aurora Cannabis. Here are the metrics that matter moving forward.
Aurora stock is under too much pressure to make it a worthwhile bet in the marijuana space right now.
Hexo stock is showing improvement on the charts, but we need a significant improvement given the lacking fundamentals and industry disdain.
By Thomas Niel
So what's the call? Aurora Cannabis is too risky to buy. But shares are even riskier to short. A crumb of good news could send shares skyrocketing. Save yourself the headache, and steer clear of the "pot bust" that is Aurora Cannabis stock.
Aurora stock is out of favor and is at risk of falling steadily over the next few quarters. But the long-term outlook of ACB stock is upbeat.
Competition will drive down pot prices in Canada. It is yet another reason to avoid Aurora stock.
Cannabis stocks are struggling to gain traction but trading opportunities are still available. Aurora stock wants to base to setup rallies.
Nothing has gone right for Aurora stock – or just about any other cannabis stock. But for investors with a strong stomach, there is potential here. Here’s a look at why.
A series of headwinds have terribly impacted ACB stock, making it one of the ugliest investments of this year. However, sentiment for marijuana legalization is growing stronger, making shares appealing from a speculative point of view.
Things have gone from bad to worse for ACB stock investors in the past month. Management needs to get serious about making some aggressive changes to get Aurora stock back on track.
Cash burn will result in further equity dilution. Medicinal cannabis growth is likely to be slow with little evidence-backed research.
With some recent bullish moves, Aurora Cannabis stock looks interesting as a contrarian trade. However, it has much to prove before anyone can offer a confident recommendation.
Cash is now king in the marijuana market, and Aurora Cannabis is among those cutting back. Aurora stock depends on U.S. legalization.
Navellier RatingsPowered by Portfolio Grader